Skip to main content
. 2024 Jan 7;15(6):439–447. doi: 10.1111/1759-7714.15211

FIGURE 1.

FIGURE 1

Kaplan–Meier curve of IDFS for patients in TAM/TOR‐only versus TAM/TOR/AI+OFS group. AI, aromatase inhibitor; CI, confidence interval; HR, hazard ratio; IDFS, invasive disease‐free survival; OFS, ovarian function suppression; TAM, tamoxifen; TOR, toremifene.